Results 241 to 250 of about 205,619 (262)

Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

Multiple Sclerosis Journal, 2018
Gavin Giovannoni, Per Soelberg Sørensen, Kottil Rammohan   +2 more
exaly  

Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing

International Journal of Pharmaceutics, 2017
Alvaro Goyanes Goyanes, Fabrizio Fina, Simon Gaisford   +2 more
exaly  

Tablet

2021
openaire   +1 more source

Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial

Nature Medicine
Paul Glue, Hsien-Yuan Lane
exaly  

Desktop 3D printing of controlled release pharmaceutical bilayer tablets

International Journal of Pharmaceutics, 2014
Jonathan C Burley, Morgan R Alexander, Clive J Roberts   +2 more
exaly  

A flexible-dose dispenser for immediate and extended release 3D printed tablets

European Journal of Pharmaceutics and Biopharmaceutics, 2015
Abdullah Isreb, Mohamed A Alhnan
exaly  

Digital light processing (DLP) 3D-printing technology and photoreactive polymers in fabrication of modified-release tablets

European Journal of Pharmaceutical Sciences, 2019
Hossam Kadry, Changxue Xu, Fakhrul Ahsan
exaly  

Tablet

2007
openaire   +1 more source

Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets

International Journal of Pharmaceutics, 2016
Muzna Sadia, Basel Arafat, Abdullah Isreb   +2 more
exaly  

Tablets

2018
openaire   +1 more source